| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 11T51Q3082 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Beta-nerve growth factor inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoarthritis, Hip | 3 | D015207 | ClinicalTrials |
| Osteoarthritis, Knee | 3 | D020370 | ClinicalTrials |
| Abdominal Pain | 2 | D015746 | ClinicalTrials |
| Sciatica | 2 | D012585 | ClinicalTrials |
| Back Pain | 2 | D001416 | ClinicalTrials |
| Low Back Pain | 2 | D017116 | ClinicalTrials |
| Osteoarthritis | 2 | D010003 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1190239-42-9 |
| ChEMBL | CHEMBL2109528 |
| FDA SRS | 11T51Q3082 |
| Guide to Pharmacology | 8965 |
CONTENTS